4.8 Article

Human CHN1 mutations hyperactivate α2-chimaerin and cause Duane's retraction syndrome

期刊

SCIENCE
卷 321, 期 5890, 页码 839-843

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1156121

关键词

-

资金

  1. Medical Research Council [G9900989, G9900837] Funding Source: researchfish
  2. Howard Hughes Medical Institute Funding Source: Medline
  3. Medical Research Council [G9900837, G9900989] Funding Source: Medline
  4. NEI NIH HHS [R01 EY015298-02, R01 EY015298-04, R01 EY015298-01, R01 EY015298-05, R01 EY015298-03, R01 EY015298] Funding Source: Medline
  5. MRC [G9900989, G9900837] Funding Source: UKRI

向作者/读者索取更多资源

Duane's retraction syndrome (DRS) is a complex congenital eye movement disorder caused by aberrant innervation of the extraocular muscles by axons of brainstem motor neurons. Studying families with a variant form of the disorder (DURS2-DRS), we have identified causative heterozygous missense mutations in CHN1, a gene on chromosome 2q31 that encodes alpha 2-chimaerin, a Rac guanosine triphosphatase-activating protein (RacGAP) signaling protein previously implicated in the pathfinding of corticospinal axons in mice. We found that these are gain-of-function mutations that increase alpha 2-chimaerin RacGAP activity in vitro. Several of the mutations appeared to enhance alpha 2-chimaerin translocation to the cell membrane or enhance its ability to self-associate. Expression of mutant alpha 2-chimaerin constructs in chick embryos resulted in failure of oculomotor axons to innervate their target extraocular muscles. We conclude that alpha 2-chimaerin has a critical developmental function in ocular motor axon pathfinding.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据